| 3/25/2025 | CAHY | New Issue: Bausch Health prices upsized $4.4 billion 10% seven-year secured notes at par
|
| 3/25/2025 | CAHY | Bausch Health talks upsized $4.65 billion secured notes due 2032 at 10%-10¼%
|
| 3/20/2025 | BKCADDHY | Moody's gives Bausch loans, notes Caa1
|
| 3/19/2025 | BKCADDHY | S&P ups Bausch, rates loans, notes B
|
| 3/19/2025 | BKCADDHY | S&P hikes Bausch + Lomb
|
| 3/19/2025 | CAHYLM | Bausch Health to redeem notes via proceeds of new notes, term loan
|
| 3/19/2025 | CAHY | Bausch Health starts roadshow for $4 billion secured notes due 2032; initial talk high-10% area
|
| 3/17/2025 | BKCAHY | Bausch Health expected to bring $4 billion to $5 billion of notes, loans in mid-to-late March
|
| 2/27/2025 | CAHY | Bausch Health expected next week with benchmark notes offering to address pending maturities
|
| 7/24/2024 | BKCADDHY | Bausch Health says it is not considering filing bankruptcy
|
| 4/18/2024 | BKCADDHY | S&P bumps up Bausch Health Cos.
|
| 9/11/2023 | BKCAHY | Moody's gives Bausch+Lomb loan, notes B1
|
| 2/28/2023 | BKCADDHY | S&P boosts Bausch Health
|
| 2/24/2023 | BKCADDHY | S&P lowers Bausch Health
|
| 10/7/2022 | BKCADDHY | Fitch cuts, ups Bausch Health
|
| 10/4/2022 | BKCACVDDHY | S&P ups Bausch, rates notes B-, CCC
|
| 9/30/2022 | BKCACVDDHY | S&P slices Bausch Health Cos.
|
| 9/30/2022 | BKCACVDDHY | Moody's cuts some Bausch Health ratings
|
| 9/28/2022 | CADDHYLM | Bausch Health gives final results of exchange offer, consent bid
|
| 9/14/2022 | CADDHYLM | Bausch Health gives early results of exchange offer, consent bid
|
| 9/8/2022 | CADDHYLM | Bausch Health clarifies provisions of exchange offer, consent bid
|
| 8/31/2022 | BKCADDHY | Fitch slashes Bausch Health
|
| 8/31/2022 | BKCADDHY | Moody's cuts Bausch Health
|
| 8/31/2022 | BKCADDHY | S&P drops Bausch Health to CC
|
| 8/31/2022 | CADDHYLM | Bausch Health launches $4 billion exchange offer, consent solicitation
|
| 8/22/2022 | BKCADDHY | Bausch Health internally transfers stock, explores strategic alternatives
|
| 8/9/2022 | BKBWCAHYLM | Bausch buys $481 million bonds at a discount; no debt due until 2025
|
| 8/1/2022 | BKCACVHY | S&P cuts Bausch Health
|
| 7/29/2022 | BKCACVHY | Moody's downgrades Bausch Health
|
| 5/31/2022 | BKCAHY | S&P cuts Bausch Health Cos.
|
| 5/13/2022 | BKCAHY | Moody's downgrades Bausch Health
|
| 5/10/2022 | CAHYLM | Bausch Health cancels redemption of 9% senior notes due 2025
|
| 4/25/2022 | CAHYLM | Bausch Health sets redemption price for 6 1/8% senior notes
|
| 4/20/2022 | BKCAHY | Fitch plans to rate Bausch + Lomb BB-, loan BB+
|
| 4/20/2022 | BKCAHY | Moody’s rates Bausch + Lomb loans Ba2
|
| 4/18/2022 | CAHYLM | Bausch Health again delays redemption of 6 1/8%, 9% senior notes
|
| 3/14/2022 | CAHYLM | Bausch Health pushes back redemption of 6 1/8%, 9% senior notes
|
| 2/24/2022 | BKBWCAHYLM | Bausch Health de-levers to 6.5x, will de-lever subsidiaries as well
|
| 1/27/2022 | CAHY | New Issue: Bausch Health prices $1 billion 6 1/8% five-year secured notes at par
|
| 1/27/2022 | BKCAHY | Moody's gives Bausch Health notes Ba3
|
| 1/27/2022 | CAHY | Bausch Health to sell $1 billion five-year secured notes on Thursday
|
| 1/27/2022 | BKCAHY | Fitch rates Bausch Health notes BB
|
| 1/27/2022 | BKCAHY | S&P assigns Bausch Health notes BB
|
| 1/18/2022 | CAHY | Bausch Health refinancing deal to include $1 billion new secured notes; guidance mid-5% area
|
| 1/18/2022 | BKCAHY | S&P rates Bausch loans BB
|
| 1/18/2022 | BKCAHY | Fitch rates Bausch facility BB
|
| 1/18/2022 | BKCAHY | Moody's rates Bausch Health loans Ba3
|
| 1/18/2022 | CAHYLM | Bausch Health intends to issue conditional notices of redemption
|
| 1/18/2022 | CAHY | Bausch Health refinancing deal to include $1 billion new secured debt
|
| 11/18/2021 | BKCAHY | Moody's alters Bausch Health view to negative
|
| 8/3/2021 | CAHYLM | Bausch Health will redeem additional $350 million 6 1/8% notes
|
| 7/1/2021 | CAHYLM | Bausch Health eyes partial redemption of 6 1/8% note due 2025
|
| 6/22/2021 | CAHYLM | Bausch Health extends tender offer for 7% secured notes due 2024 to reflect new federal holiday
|
| 6/7/2021 | CAHYLM | Bausch Health sees early tenders of $545.08 million 7% notes due 2024
|
| 5/27/2021 | CAHYLM | Bausch Health to redeem C$100 million 6 1/8% notes due 2025
|
| 5/24/2021 | CAHY | New Issue: Bausch Health prices $1.6 billion seven-year secured notes at par to yield 4 7/8%
|
| 5/24/2021 | BKCAHY | Fitch gives Bausch Health notes BB
|
| 5/24/2021 | CAHY | Bausch Health to sell $1.6 billion seven-year secured notes on Monday
|
| 5/24/2021 | CAHYLM | Bausch Health commences tender offer for 7% secured notes due 2024
|
| 5/24/2021 | BKCAHY | S&P assigns Bausch Health notes BB
|
| 5/24/2021 | BKCAHY | Moody's rates Bausch Health notes Ba2
|
| 5/5/2021 | BKCAHY | Fitch revises Bausch Health view to negative
|
| 5/4/2021 | BKCAHY | S&P alters Bausch Health view to negative
|
| 5/3/2021 | CAHYLM | Bausch Health to redeem C$100 million more 7% secured notes on June 2
|
| 4/7/2021 | CAHYLM | Bausch Health to redeem C$100 million more 7% secured notes due 2024
|
| 2/26/2021 | CAHYLM | Bausch Health to redeem C$100 million 7% senior notes due 2024
|
| 2/24/2021 | BKBWCAHY | Bausch repays $900 million debt in 2020, targets $1 billion for 2021
|
| 2/22/2021 | CAHYLM | Bausch Health to redeem C$100 million of 7% senior notes due 2024
|
| 1/13/2021 | BKBWCAHY | Bausch Health aims to cut leverage via debt paydowns, higher EBITDA
|
| 12/1/2020 | BKBWCAHY | Bausch management seeks to cut leverage as company is ‘very levered’
|
| 11/18/2020 | CAHYLM | Bausch Health eyes redemption of 4½%, 5½% notes due 2023
|
| 11/18/2020 | CAHY | New Issue: Bausch Health prices upsized $2 billion senior notes in two tranches
|
| 11/18/2020 | CAHYLM | Bausch Health to redeem all €1.5 billion 4.5% senior notes due 2023
|
| 11/18/2020 | CAHY | Bausch Health to sell $1.75 billion of notes in two parts on Wednesday
|
| 11/18/2020 | BKCAHY | S&P assigns Bausch Health notes B
|
| 11/18/2020 | BKCAHY | Moody’s gives Bausch Health notes B3
|
| 11/18/2020 | BKCAHY | Fitch rates Bausch Health notes B
|
| 10/29/2020 | CAHYLM | Bausch Health to redeem 5 7/8% notes, C$50 million of 5½% notes
|
| 8/31/2020 | CAHYLM | Bausch Health to redeem C$100 million 5 7/8% senior notes due 2023
|
| 5/11/2020 | BKCAHY | S&P rates Bausch Health notes B
|
| 5/11/2020 | CAHY | New Issue: Bausch Health prices upsized $1.5 billion 6¼% notes due 2029 at par
|
| 5/11/2020 | BKCAHY | Fitch rates Bausch Health notes B
|
| 5/11/2020 | BKCAHY | Moody’s rates Bausch Health notes B3
|
| 5/11/2020 | CAHYLM | Bausch Health conditionally calls $1.25 billion 6½% notes due 2022
|
| 5/11/2020 | CAHY | Bausch Health talks $1.25 billion notes due 2029 to yield 6¼%-6½%; pricing Monday
|
| 3/2/2020 | BKCAHYLM | Bausch cancels plans for new notes, loan refinancing, redemption
|
| 2/21/2020 | BKCAHY | S&P gives Bausch Health loan, notes BB
|
| 2/20/2020 | BKCAHY | Fitch rates Bausch Health Americas facility, notes BB
|
| 2/19/2020 | CAHYLM | Bausch Health will redeem 6½% notes due 2022, 7% notes due 2024
|
| 2/19/2020 | CAHY | Bausch Health plans to issue C$3.25 billion of new notes
|
| 2/12/2020 | CAHYLM | Bausch Health to redeem C$100 million 5½% notes due 2023
|
| 12/18/2019 | CAHYLM | Bausch Health calls $1.24 billion 5 7/8% notes due 2023
|
| 12/17/2019 | CAHY | New Issue: Bausch Health prices upsized $2.5 billion notes in two tranches
|
| 12/17/2019 | CAHY | S&P gives Bausch Health notes B
|
| 12/17/2019 | CAHY | Moody’s assigns B3 to Bausch notes
|
| 12/17/2019 | CAHY | Fitch rates Bausch notes B
|
| 12/17/2019 | CAHY | Bausch Health to shop $1.25 billion two-part senior notes offering on Tuesday investor call
|
| 12/16/2019 | CAHY | S&P upgrades Bausch Health
|
| 11/4/2019 | BKBWCAHY | Bausch pays down debt in search of ‘more reasonable’ capital structure
|
| 9/3/2019 | CAHYLM | Bausch Health to reduce debt by $200 million via paydown, redemption
|
| 5/23/2019 | CAHYLM | Bausch Health tender offer for 5½% notes, 5 7/8% notes oversubscribed
|
| 5/9/2019 | CAHY | New Issue: Bausch Health prices $1.5 billion senior notes in two tranches
|
| 5/9/2019 | CAHY | S&P rates Bausch Health notes B-
|
| 5/9/2019 | CAHY | Moody's rates Bausch Health notes B3
|
| 5/9/2019 | CAHY | Bausch Health to sell $1.5 billion of notes in two parts on Thursday
|
| 5/9/2019 | CAHYLM | Bausch launches tender offer for up to $1.5 billion of 2023 notes
|
| 5/9/2019 | CAHY | Fitch rates Bausch notes B
|
| 5/6/2019 | BKBWCAHY | Bausch Health retires $158 million debt in Q1, plans to boost EBITDA
|
| 5/2/2019 | CAHY | Fitch upgrades Bausch Health
|
| 3/8/2019 | CAHYLM | Bausch Health calls 2021 notes, announces early tender results
|
| 3/8/2019 | CAHYLM | Bausch Health announces early results of tender offers for notes
|
| 2/25/2019 | CAHYLM | Bausch Health ups tender offer price to $1.5 billion for three notes
|
| 2/25/2019 | BKCAHY | S&P rates Bausch Health
|
| 2/22/2019 | CAHY | New Issue: Bausch Health prices upsized $1.5 billion notes in two tranches
|
| 2/22/2019 | BKCAHY | Moody’s rates Bausch Health notes Ba2, B3
|
| 2/22/2019 | BKCAHY | Fitch rates Bausch Health notes BB-
|
| 2/22/2019 | CAHYLM | Bausch Health holds $1.25 billion tender offer for three note series
|
| 2/22/2019 | CAHY | Bausch Health to price $1.25 billion two-part notes offering Friday
|
| 11/30/2018 | CAHYLM | Bausch Health to call $200 million 5 5/8% notes due 2021 on Dec. 31
|
| 11/27/2018 | CAHYLM | Bausch Health to redeem remaining 7½% notes due 2021 on Dec. 27
|
| 11/21/2018 | CAHYLM | Bausch Health sees $1.48 billion early tenders of 7½% notes due 2021
|
| 11/9/2018 | BKCAHY | S&P affirms Bausch Health
|
| 11/8/2018 | BKCADDHY | Moody's upgrades Bausch
|
| 11/7/2018 | CAHYLM | Bausch Health tenders, solicits consents for 7½% notes due 2021
|
| 9/26/2018 | CAHYLM | Bausch Health calls $125 million 7½% notes due 2021
|
| 8/23/2018 | BKCADDHY | Moody’s ups Bausch SGL, changes view
|
| 5/8/2018 | BKBWCAHYLM | Valeant cuts debt by $6.9 billion since 2016; ‘more work to be done’
|
